Comparative Pharmacology
Head-to-head clinical analysis: LAX LYTE WITH FLAVOR PACKS versus LAXILOSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LAX LYTE WITH FLAVOR PACKS versus LAXILOSE.
LAX-LYTE WITH FLAVOR PACKS vs LAXILOSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic laxative: polyethylene glycol (PEG) retains water in the intestinal lumen, increasing stool volume and stimulating peristalsis. Electrolytes (sodium, potassium, chloride, bicarbonate) prevent electrolyte depletion.
Laxilose (lactulose) is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, it is metabolized by bacteria to short-chain fatty acids (e.g., lactic, acetic, formic acids), which osmotically draw water into the bowel lumen, stimulating peristalsis and softening stools. Additionally, in hepatic encephalopathy, colonic acidification traps ammonia (NH3) as ammonium (NH4+), reducing systemic ammonia absorption.
Oral: 1 to 2 packets (4 to 8 g of polyethylene glycol 3350) dissolved in 4 to 8 ounces of water once daily, as needed for constipation. Maximum: 2 packets per day.
10-20 g (15-30 mL) orally once daily; may increase to 40 g (60 mL) daily in divided doses.
None Documented
None Documented
Terminal elimination half-life is 6-8 hours in patients with normal renal function; prolonged in renal impairment (up to 20 hours).
Terminal elimination half-life is 2.5-4 hours in patients with normal renal function; prolonged to up to 20 hours in severe renal impairment.
Primarily renal (30-50% unchanged) and biliary/fecal (50-70% as inactive metabolites).
Primarily renal excretion, with approximately 40% of the dose recovered as unchanged drug in urine; biliary/fecal excretion accounts for the remainder, including metabolites.
Category C
Category C
Laxative
Laxative